Comparison of [68Ga]Ga-CTR-FAPI and 18F-FDG PET/MRI for Lymph Node Staging in Rectal Cancer
- Sponsor
- Peking University Cancer Hospital & Institute
- Study ID
- NCT07552207
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Lymph Node Metastases
- PET / MR
- Rectal Cancer
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 75 Years
- Healthy Volunteers
- Not accepted
Interventions
- PET/MRI with 18F-FDG and [68Ga]Ga-CTR-FAPI — DIAGNOSTIC_TESTDiagnostic Test: 18F-FDG PET/MRI Description: Patients receive an intravenous injection of 18F-FDG (3.7-5.5 MBq/kg). Diagnostic Test: \[68Ga\]Ga-CTR-FAPI PET/MRI Description: Patients receive an intravenous injection of \[68Ga\]Ga-CTR-FAPI (1.8-3.7 MBq/kg).
Study Details
This is a prospective, single-center, diagnostic study designed to compare the accuracy of \[68Ga\]Ga-CTR-FAPI PET/MRI and \[18\]F-FDG PET/MRI for the detection of lymph node metastasis in patients with initially untreated, resectable middle to high rectal cancer. The study aims to evaluate whether \[68Ga\]Ga-CTR-FAPI PET/MRI provides higher sensitivity and specificity than traditional 18F-FDG PET/MRI at both the patient level and the lymph node level.
Key Dates
- First listed
- Apr 27, 2026
- Start date
- Apr 1, 2026
- Status verified
- Jan 2026
- Primary completion
- Dec 31, 2027
- Completion
- Dec 31, 2028
Study Design
- Enrollment
- 30 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- DIAGNOSTIC
Arms
- Experimental: Rectal Cancer PatientsPatients with confirmed middle to high rectal adenocarcinoma who are scheduled for radical surgery.
Primary Outcome Measure
Sensitivity and Specificity of Lymph Node Metastasis Detection [ Time Frame: Up to 30 days post-surgery ]
Central Contacts
- Minghe Zhao0086-15600896700
Find similar trials
Related Studies
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 PatientsPHASE1/PHASE2 · Recruiting · National Cancer Institute (NCI) · Bethesda, Maryland
- Distribution of Lymph Node Metastases in Esophageal CarcinomaRecruiting · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Houston, Texas
- Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal CancerPHASE1/PHASE2 · Recruiting · Washington University School of Medicine · Boston, Massachusetts